According to the recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer (GC‐HBOC), all women diagnosed with epithelial ovarian cancer (OC) before the age of 80 years should have germline genetic testing of BRCA1/2 and other OC predisposition genes, irrespective of their tumor histology or family cancer history.1 This evidence concerns the gene BRCA1 and neoplasm.